top of page
News, Events and Updates
Search
Independent Research Describes ANAVEX 3-71 as Potent Cognitive Enhancer in Alzheimer's Disease Model
Nov 30, 2015
New Exploratory Alzheimer's Drug ANAVEX 2-73: Assessment of Safety and Cognitive Performance
Nov 27, 2015
Anavex Announces Executive Overseeing Regulatory Affairs
Nov 25, 2015
Anavex to Present at American Epilepsy Society Annual Meeting ANAVEX 2-73 Shows Anti-Seizure Effects
Nov 19, 2015
Anavex Announces Preparation of Regulatory Filings based on Guidance From the FDA
Nov 18, 2015
Anavex Confirms Data for Phase 2a Alzheimer's Trial for ANAVEX 2-73
Nov 11, 2015
New Exploratory Alzheimer's Drug ANAVEX 2-73 Changes in Electrophysiological Markers in Alzheimer's
Nov 11, 2015
Anavex Announces Positive Primary and Secondary Endpoints were Achieved in a Phase 2a Clinical Trial
Nov 9, 2015
Anavex Announces CTAD 2015 Abstract
Nov 5, 2015
Anavex Commences Trading on NASDAQ Today — To Ring Friday's Closing Bell
Oct 27, 2015
Anavex Announces Uplisting to NASDAQ
Oct 25, 2015
33
34
35
36
37
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
